Ramiz Boulos

Ramiz Boulos is a researcher at Flinders University's Department of Biological Sciences, actively engaged as a media expert in antibiotics, microbiology, and nanotechnology. His university affiliation is maintained through research commercialization activities and media contributions despite primary focus on industry ventures.

His educational credentials include:

• PhD in Chemistry (2011, University of Western Australia)
• Honours in Chemistry (2005, University of Western Australia)
• BSc in Chemistry and Genetics (2004, University of Western Australia)

Boulos pioneered research on mechanosensitive ion channels as antimicrobial targets during his PhD, leading to novel non-toxic agents against gram-positive superbugs. His interdisciplinary work spans biomass waste valorization, calcium carbonate biomineralisation under high shear, and molecular modelling to interpret experimental outcomes. These efforts bridge pharmaceutical development, sustainable materials science, and computational chemistry with practical industrial applications.

His recognitions include:

• Tall Poppy Award (2014)
• 2nd Prize Poster Presentation at Flinders CNST Conference (2013)

Commercialization defines Boulos's career trajectory: he founded Boulos & Cooper Pharmaceuticals (2013-2020) to advance his antibiotic discoveries, and currently serves as Executive Chairman of Veratin (founded 2016) developing low-grade wool applications. Through Founders First and Boulos & Cooper Labs, he drives IP commercialization and R&D, demonstrating sustained translation of academic research into market solutions without traditional academic advising roles.

His entrepreneurial ecosystem functions as a de facto research team, focusing on antimicrobial development and sustainable material innovation while maintaining Flinders University as an intellectual anchor for media engagement and scientific credibility.